Financial reports
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
18 Aug 23
NT 10-Q
Notice of late quarterly filing
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
16 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-K/A
2021 FY
Annual report (amended)
20 Sep 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
Current reports
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7 Feb 24
8-K
Bankruptcy or Receivership
5 Feb 24
8-K
Submission of Matters to a Vote of Security Holders
31 Jan 24
8-K
Material Modifications to Rights of Security Holders
23 Jan 24
8-K
Submission of Matters to a Vote of Security Holders
3 Jan 24
8-K
Regulation FD Disclosure
3 Jan 24
8-K
Termination of a Material Definitive Agreement
21 Dec 23
8-K
Submission of Matters to a Vote of Security Holders
4 Dec 23
8-K
DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI® and Provides Corporate Update
28 Nov 23
8-K
Submission of Matters to a Vote of Security Holders
15 Nov 23
Registration and prospectus
25-NSE
Exchange delisting
21 Mar 24
424B4
Prospectus supplement with pricing info
3 Aug 23
S-1/A
IPO registration (amended)
28 Jul 23
FWP
Free writing prospectus
27 Jul 23
S-1/A
IPO registration (amended)
26 Jul 23
S-1
IPO registration
13 Jul 23
D
Indefinite amount in equity / options, 12 investors
12 Jun 23
424B5
Prospectus supplement for primary offering
14 Mar 23
424B5
Prospectus supplement for primary offering
23 Sep 22
S-3
Shelf registration
9 Sep 22
Proxies
DEFA14A
Additional proxy soliciting materials
23 Jan 24
DEFA14A
Additional proxy soliciting materials
3 Jan 24
DEFA14A
Additional proxy soliciting materials
4 Dec 23
DEFA14A
Additional proxy soliciting materials
15 Nov 23
DEFA14A
Additional proxy soliciting materials
15 Nov 23
DEFA14A
Additional proxy soliciting materials
15 Nov 23
PX14A6G
Letter to shareholders
17 Oct 23
DEFC14A
Proxy in contested solicitation
12 Oct 23
PREC14A
Preliminary proxy with contested solicitation
2 Oct 23
DEFA14A
Additional proxy soliciting materials
5 May 23
Other
EFFECT
Notice of effectiveness
2 Aug 23
CORRESP
Correspondence with SEC
28 Jul 23
CORRESP
Correspondence with SEC
28 Jul 23
CORRESP
Correspondence with SEC
28 Jul 23
CORRESP
Correspondence with SEC
28 Jul 23
CORRESP
Correspondence with SEC
26 Jul 23
CORRESP
Correspondence with SEC
26 Jul 23
EFFECT
Notice of effectiveness
20 Sep 22
CORRESP
Correspondence with SEC
16 Sep 22
UPLOAD
Letter from SEC
14 Sep 22
Ownership
SC 13G/A
INTRACOASTAL CAPITAL, LLC
6 Feb 24
4
John W. Jr. Dorbin
2 Nov 23
3
John W. Jr. Dorbin
2 Nov 23
4
SETH COHEN
25 Oct 23
3
SETH COHEN
25 Oct 23
SC 13D/A
Versi Group LLC
26 Sep 23
4
Ebrahim Versi
19 Sep 23
SC 13G
INTRACOASTAL CAPITAL, LLC
10 Aug 23
SC 13D
Versi Group LLC
5 Jun 23
4
Ebrahim Versi
30 May 23